David I. Malek
Director · Braveheart Bio, Inc.
IndividualBuying only
- 2026
- Aug 7, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David I. Malek files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $34.92M in BRVE purchases and sales in the last 12 months
- Erez Chimovits - $34.92M in BRVE purchases and sales in the last 12 months
- AH Bio Fund IV, L.P. - $19.80M in BRVE purchases and sales in the last 12 months
- Christopher Viehbacher - $1.50M in BRVE purchases and sales in the last 12 months
- Travis Murdoch - $1.50M in BRVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David I. Malek?
David I. Malek is a corporate insider, tracked as Director of Braveheart Bio, Inc. (BRVE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David I. Malek submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David I. Malek been buying or selling stock?
Recorded transactions: 1 open-market purchase ($75K) and 0 open-market sales across all tracked filings.
